Urothelial Cancer Clinical Trials
3 recruiting trials for Urothelial Cancer. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT04923178
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Background: Tumors in the genitourinary tracts can occur in the kidney, bladder, prostate, and testicles and can have common and rare histologies. Some cancers that occur along...
Sponsor: National Cancer Institute (NCI)Enrolling: 11001 location
RECRUITINGNCT02379429
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
Background: Urothelial cancer is cancer of the bladder, ureter, and urethra. Researchers want to better understand what changes in a person s cells and genes cause this cancer to...
Sponsor: National Cancer Institute (NCI)Enrolling: 5001 location
RECRUITINGNCT06011954
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Enfortumab vedotin (or PADCEV Injection) is a treatment for cancer in the bladder lining (urothelial cancer). PADCEV Injection is now available to treat this cancer. People in...
Sponsor: Astellas Pharma Korea, Inc.Enrolling: 20218 locations